Gene · 100187828
Papers1,868
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,868
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomics reveals specific biological changes induced by the normothermic machine perfusion of donor kidneys with a significant up-regulation of Latexin. | Sci Rep | 2023 | 37041202 | PubTator, text mining | PubMed |
| Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease. | Front Immunol | 2023 | 37026010 | PubTator, text mining | PubMed |
| Novel asymmetrical azines appending 1,3,4-thiadiazole sulfonamide: synthesis, molecular structure analyses, in silico ADME, and cytotoxic effect. | RSC Adv | 2023 | 37020890 | PubTator, text mining | PubMed |
| In-depth proteomics reveals the characteristic developmental profiles of early lung adenocarcinoma with epidermal growth factor receptor mutation. | Cancer Med | 2023 | 37004157 | PubTator, text mining | PubMed |
| Low human beta-defensin-2 levels in the sputum of COPD patients are associated with the risk of exacerbations. | BMC Pulm Med | 2023 | 37003996 | PubTator, text mining | PubMed |
| Light-activated macromolecular phase separation modulates transcription by reconfiguring chromatin interactions. | Sci Adv | 2023 | 37000871 | PubTator, text mining | PubMed |
| Genetic regulation of fetal hemoglobin across global populations. | medRxiv | 2023 | 36993312 | PubTator, text mining | PubMed |
| Gene Therapy for β-Hemoglobinopathies: From Discovery to Clinical Trials. | Viruses | 2023 | 36992422 | PubTator, text mining | PubMed |
| Coexisting Conditions Modifying Phenotypes of Patients with 22q11.2 Deletion Syndrome. | Genes (Basel) | 2023 | 36980952 | PubTator, text mining | PubMed |
| Epigenetic Regulation of β-Globin Genes and the Potential to Treat Hemoglobinopathies through Epigenome Editing. | Genes (Basel) | 2023 | 36980849 | PubTator, text mining | PubMed |
| Human β-Defensins in Diagnosis of Head and Neck Cancers. | Cells | 2023 | 36980171 | PubTator, text mining | PubMed |
| High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on in vitro mRNA synthesis. | Front Genome Ed | 2023 | 36969374 | PubTator, text mining | PubMed |
| Editorial: Immunosenescence after sepsis. | Front Immunol | 2023 | 36969160 | PubTator, text mining | PubMed |
| Multiscale network analysis identifies potential receptors for SARS-CoV-2 and reveals their tissue-specific and age-dependent expression. | FEBS Lett | 2023 | 36951513 | PubTator, text mining | PubMed |
| Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19. | J Clin Immunol | 2023 | 36943669 | PubTator, text mining | PubMed |
| Microneedle-based interstitial fluid extraction for drug analysis: Advances, challenges, and prospects. | J Pharm Anal | 2023 | 36908860 | PubTator, text mining | PubMed |
| Integrated Bioinformatics Analysis of Shared Genes, miRNA, Biological Pathways and Their Potential Role as Therapeutic Targets in Huntington's Disease Stages. | Int J Mol Sci | 2023 | 36902304 | PubTator, text mining | PubMed |
| A Particular Focus on the Prevalence of α- and β-Thalassemia in Western Sicilian Population from Trapani Province in the COVID-19 Era. | Int J Mol Sci | 2023 | 36902239 | PubTator, text mining | PubMed |
| Potential antiviral activities of chrysin against hepatitis B virus. | Gut Pathog | 2023 | 36895013 | PubTator, text mining | PubMed |
| Endemic Burkitt lymphoma avatar mouse models for exploring inter-patient tumor variation and testing targeted therapies. | Life Sci Alliance | 2023 | 36878637 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/100187828/papers?page=14